In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...
Background Introduction of guideline-directed medical therapy (GDMT) has transformed the care of heart failure (HF) with ...
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart ...
A sweeping international study has identified ways to detect patients who are at serious risk of sudden death, heart failure ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Some people with heart failure need to take multiple medicines each day in order to keep their symptoms under control. Heart failure not only leads to issues in the heart but other organs in the body ...
Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...
Copyright: © 2026 Daidone et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits ...
“Our findings revealed that in subjects with ADHF, treatment with i.v. furosemide plus HSS significantly decreased the serum levels of IL-6, sST2, hsTnT, galectin-3, and NT-proBNP and modulated some ...
The pandemic may have passed, but COVID-19 continues to have an impact. New research has tied the virus to an increase in deaths from heart failure – a progressive disease in which the heart’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results